reports
- Bruno Cavalier
Qui pour discipliner les finances publiques françaises ?
En 2007, avant la crise financière, la dette publique rapportée à la population française représentait 20.000 euros par personne. En 2023, c’était 45.000. Dans deux ans, ce sera 50.000. Nul besoin d’être expert dans la théorie ricardienne de la dette, ni d’attendre l’avis des agences de notation, pour voir que quelque chose ne va pas. Bien que le budget 2024 fût obsolète dès mars, le gouvernement a refusé de présenter un budget rectificatif. Cela aurait été malvenu dit-on avant l...
Mobilicom CEO Oren Elkayam to Participate in Fireside Chat at the “Cha...
Mobilicom CEO Oren Elkayam to Participate in Fireside Chat at the “Charting the Course: Navigating the Intersection of TMT and Business in the AI Era” Conference, presented by Maxim Group LLC, on June 5, 2024 Shoham, Israel, June 03, 2024 (GLOBE NEWSWIRE) -- Limited (Nasdaq: MOB, MOBBW), a provider of cybersecurity and robust solutions for drones and robotics, today announced its CEO and Co-Founder, Oren Elkayam, will participate in a fireside chat at the Maxim Group Virtual TMT Conference at 8:30 am ET on Wednesday, June 5, 2024 with Maxim’s Senior Analyst. As a leader in cyb...
Greek Organisation Of Football Prognostics S.A.: 1 director
A director at Greek Organisation Of Football Prognostics S.A. bought 9,950 shares at 15.050EUR and the significance rating of the trade was 65/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's director...
Falabella Sociedad Anomina Comercial E Industrial: 3 directors
Three Directors at Falabella Sociedad Anomina Comercial E Industrial bought 549,344 shares at between 2,796.086CLP and 2,800.000CLP. The significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary t...
Scandinavian Tobacco Group AS: 1 director
A director at Scandinavian Tobacco Group AS sold 35,707 shares at 96.970DKK and the significance rating of the trade was 85/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two...
uniQure Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Des...
uniQure Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Investigational Gene Therapy AMT-130 in Huntington’s Disease ~ Designation based on 24-month interim Phase I/II clinical data for AMT-130 announced in December 2023 ~ ~ AMT-130 is the first therapeutic candidate to receive RMAT Designation for Huntington’s disease ~ ~ Receiving RMAT designation enables increased collaboration with the FDA on regulatory approval planning, in addition to the opportunity for expedited product development ~ LEXINGTON, Mass. and AMSTERDAM, June 03, 2024 (GLOBE NEWSWIRE) -- N...
Enthusiast’s Luminosity Hosts Get On My Level X to Over 200,000 Unique...
Enthusiast’s Luminosity Hosts Get On My Level X to Over 200,000 Unique Online Viewers Get On My Level X reached over 200,000 unique online viewers, 60,000 concurrent viewers, and 2,500 live in-person attendees LOS ANGELES, June 03, 2024 (GLOBE NEWSWIRE) -- (“Enthusiast Gaming” or the “Company”) (TSX: EGLX), a leading gaming and media company, today announced that its 10th anniversary edition of the Get On My Level event, hosted by Luminosity in partnership with Even Matchup Gaming, reached over 200,000 unique online viewers and peaked at over 60,000 concurrent online viewers while hos...
Kraig Biocraft Laboratories Announces BAM-1 Spider Silk Hybrids are in...
Kraig Biocraft Laboratories Announces BAM-1 Spider Silk Hybrids are in Production ANN ARBOR, Mich., June 03, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), announces today that Kraig Labs is now in production with its BAM-1 recombinant spider silk hybrids. The Company originally planned this launch for July, but the resounding successes of the production trials positioned Kraig Labs to accelerate its 2024 production schedule. This production cycle serves as a critical transition for the Company’s commercialization of sustainable ...
Prelude Therapeutics to Participate in Upcoming Healthcare Conferences
Prelude Therapeutics to Participate in Upcoming Healthcare Conferences WILMINGTON, Del., June 03, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will participate in two upcoming healthcare conferences in June. Jefferies Global Healthcare Conference 2024:On Thursday, June 6th, at 1:30 p.m. ET, Kris Vaddi, Ph.D., Chief Executive Officer of Prelude will participate in a fireside chat. A live webcast of the fireside chat can be accessed . Goldman Sachs 45th Annual Global Healthcare Conference:On Wednesday, June 12th, a...
FibroGen to Present at Goldman Sachs 45th Annual Global Healthcare Con...
FibroGen to Present at Goldman Sachs 45th Annual Global Healthcare Conference SAN FRANCISCO, June 03, 2024 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that Thane Wettig, Chief Executive Officer, will participate in a Fireside Chat at Goldman Sachs 45th Annual Global Healthcare Conference to be held in Miami, Florida on Monday, June 10, 2024, from 10:00-10:35 AM Eastern Time. Company management will also participate in one-on-one meetings with investors during the conference. A live audio webcast of the event will be available to investors and other interested partie...
Alector to Participate in the Goldman Sachs 45th Annual Global Healthc...
Alector to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference SOUTH SAN FRANCISCO, Calif., June 03, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced that management will participate in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference on Monday, June 10, 2024, at 1:20 p.m. ET. A live webcast of the fireside chat will be available on the “Events & Presentations” page within the Investors section of the Alector website at . A replay will be available ...
Beyond Cancer Presents First-in-Class Clinical Data Showing an Immunog...
Beyond Cancer Presents First-in-Class Clinical Data Showing an Immunogenic Response in Subjects with r/r Unresectable Solid Tumors Treated with Ultra-High Concentration Nitric Oxide (UNO) – Ongoing Phase 1a first-in-human clinical trial continues to demonstrate proof of concept for the UNO solid tumor platform with observed early tumor responses and clinical resolution of radiation dermatitis – Phase 1a data continue to support feasibility of administering UNO at ultra-high concentrations with immune biomarkers at 50,000 parts per million (ppm) demonstrating an immunogenic response ...
Axsome Therapeutics Supports Alzheimer’s & Brain Awareness Month
Axsome Therapeutics Supports Alzheimer’s & Brain Awareness Month NEW YORK, June 03, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, announced today it is supporting Alzheimer’s & Brain Awareness Month this June, to help increase awareness and understanding of the challenges Alzheimer’s disease (AD) presents to patients, their caregivers, and their loved ones, and the importance of brain and mental health as cornerstones of overall health. ...
District Court Issues Favorable Ruling and Denies United Therapeutics’...
District Court Issues Favorable Ruling and Denies United Therapeutics’ Request to Block YUTREPIA™ Launch On May 31, Judge Andrews denied United Therapeutics’ motion for a preliminary injunction to block the launch of YUTREPIA in the PH-ILD indicationRuling reinforces the clear path for FDA to issue final decision on amended NDA for YUTREPIA to treat both PAH and PH-ILD MORRISVILLE, N.C., June 03, 2024 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that on May 31, Judge Andrews of the U.S. District Court for the District of Delaware (District Court) denied the mot...
ATHA Energy Commences 2024 Angilak Diamond Drilling Exploration Progra...
ATHA Energy Commences 2024 Angilak Diamond Drilling Exploration Program HIGHLIGHTS: Angilak Project: The Angilak Project is host to the Lac 50 Uranium Deposit, which is one of the largest high-grade deposits outside of the Athabasca Basin, with a historical mineral resource estimate of 43.3M lbs at an average grade of 0.69% U3O8.1 Drilling in 2023 by Latitude Uranium (acquired by ATHA) intersected grades of up to 7.54 % U3O8 over 1.6 m.2024 Angilak Exploration Program is part of the Company’s overall 2024 Exploration Program and consists of Phase I (diamond drilling)...
NewGenIvf Signs Non-Binding Term Sheet for Potential Reverse Merger wi...
NewGenIvf Signs Non-Binding Term Sheet for Potential Reverse Merger with COVIRIX BANGKOK, Thailand, June 03, 2024 (GLOBE NEWSWIRE) -- NewGenIvf Group (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced the execution of a non-binding term sheet (the "Term Sheet") regarding a proposed reverse merger (the “Proposed Transaction”) with pharmaceutical company COVIRIX Medical Pty Ltd ("COVIRIX"). Mr. Siu Wing Fung Alfred, Founder, Chairman, and CEO of NewGen comment...
Canoo Announces Participation in June Investor Conferences
Canoo Announces Participation in June Investor Conferences JUSTIN, Texas, June 03, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: ), a high-tech advanced mobility company, today announced that company leadership will participate in the following investor conferences in June: Stifel Cross Sector Insight Conference Boston, MassachusettsJune 4 -5, 2024 CFO Greg Ethridge will participate in a fireside chat on June 4 at 4:10 p.m. ET. Sidoti Small Cap ConferenceVirtualJune 12-13, 2024 CFO Greg Ethridge and Vice President of Capital Markets and Investor Relations Jonathan Wolff will host a 30-...
Smart Share Global Limited Announces First Quarter 2024 Results
Smart Share Global Limited Announces First Quarter 2024 Results POIs1 operated through network partner model reached 79.7% as of the end of the first quarter of 2024Cumulative registered users2 reached 404.3 million as of the end of the first quarter of 2024 SHANGHAI, China, June 03, 2024 (GLOBE NEWSWIRE) -- Smart Share Global Limited (Nasdaq: EM) (“Energy Monster” or the “Company”), a consumer tech company providing mobile device charging service, today announced its unaudited financial results for the quarter ended March 31, 2024. HIGHLIGHTS FOR THE FIRST QUARTER OF 2024 As of March ...
Skye Bioscience to Present at Jefferies Global Healthcare Conference
Skye Bioscience to Present at Jefferies Global Healthcare Conference Skye provides webcast link for corporate presentation SAN DIEGO, June 03, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel classes of therapeutic drugs that modulate the endocannabinoid system, today announced that Chief Executive Officer & Chair, Punit Dhillon, will present an overview of the company and its programs in obesity and glaucoma at the Jefferies Global Healthcare Conference bei...
Talisker Provides Update on the Second Draw on the US$31,250,000 Finan...
Talisker Provides Update on the Second Draw on the US$31,250,000 Financing with Sprott Streaming and Royalty for the Bralorne Gold Project TORONTO, June 03, 2024 (GLOBE NEWSWIRE) -- Talisker Resources Ltd. (“Talisker” or the “Company”) (TSX: TSK, OTCQX: TSKFF) is pleased to provide an update that, pursuant to the previously announced royalty agreement (the “Agreement”) with Sprott Resource Streaming and Royalty Corp. (“Sprott”) in relation to the Company’s 100% owned Bralorne Gold Project, Sprott has approved the second draw of US$11,750,000, subject to conclusion of amended documentation...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.